Roslyn Hendriks Email & Phone Number

Woolloongabba, Queensland, AU

Bruce, ACT, AU

Brisbane, Queensland, AU

UQ Founders Pledge is an entrepreneurial network of Founders creating positive change and making commitments to give back to UQ in the future.

Noosaville, Australia, AU

Austin, Texas, US

Adelaide, South Australia, AU

Westmead, NSW, AU

Parkville, Victoria, AU

Mawson Lakes, SA, AU

Seattle, WA, US

Seattle, WA, US

Unlocking access to and understanding of the super healing power of the gut microbiome

Greater Seattle Area, WA, US

Boutique consulting agency helping small business owners, entrepreneurs and technology transfer professionals to TRANSFORM their businesses to build higher value enterprises. Advisors and Advisory Board member/s of GMJ Technologies (Seattle), Provectus Algae (Australia), Tend Health (USA), Westmead Institute for Medical Research (WIMR) (Australia), Walter.

Equity portfolio of investments in 26 Australian start-up companies, including Protagonist Therapeutics Inc. (PTGX: NASDAQ), Immunexpress (Seattle), Implicit Bioscience, Verva Pharmaceuticals Ltd, Magnetica, Arana Therapeutics, Gen3 Media, and others. Original investment in portfolio: $6M (AUD)

Darlinghurst, NSW, AU

Oak Brook, Illinois, US

NextLevel is a Pacific Northwest-based professional services firm with national resources, providing executive and board services on an interim, project and advisory basis. We deliver a broad range of strategic, operational and financial management services through vetted, expert team members who have an average of two decades of experience serving in.

Melbourne, VIC, AU

Melbourne, VIC, AU

Molecular diagnostics – Medtech Insight Award-winning SeptiCyte disruptive technology that analyzes by artificial intelligence (AI) the immune system to rapidly detect sepsis and help clinicians and patients fight one of the world’s most life-threatening diseases.

Raised 42.5M in dilutive & non-dilutive capital (seed, Series A & B, Convertible Notes, grants, R&D tax refunds)Developed Medtech Insight Award-Winning SeptiCyte technology to FDA 510(k) clearanceConducted extensive retrospective economics to demonstrate potential value in Accountable Care Organizations (ACOs)Established major international partnerships.

Raises financial support for research and educational collaborations with US partners, friends and alumni to benefit all stakeholders of The University of Queensland.Served under Chairman, Andrew LiverisFounding member; supported establishment of 501(c)(3) status, corporate governance routines, board composition, brand enhancement, foundation activities in.

• Specialist in corporate governance, strategy development and IP management for technology commercialization from universities, government business organizations, medical research institutes and spin-offs.
• Architect of structural change to better enable commercialization
• Spin-offs and economic development.

Start-up developing gene expression-based monitoring technologies for infectious and inflammatory diseases in performance horses. World’s first Affymetrix (now Thermo-Fisher) Genechip for the equine.Raised $15M in dilutive and non-dilutive capital (Seed, Series A, Convertible Notes)International business and market development.

Brisbane, Queensland, AU

• Australia’s leading commercialization entity; intellectual property of The University of Queensland, a global top 50 university. Uniquest benchmarks in top tier of technology transfer worldwide.
• With Executive Director, turned-around from loss to profit
• Doubled turnover in less than one year
• Managed $35M in syndicated R&D projects
• Developed IP and external relations for Gardisil vaccine project.

Brisbane, Queensland, AU

Brisbane, Queensland, AU

Brisbane, Queensland, AU

Davis, California, US

Course work study prior to thesis commencement at the University of Queensland.

Paris, FR

Perth, Western Australia, AU

Phd, Medicine, Pharmacology

Mba, Business

Veterinary Medicine, Clinical Medicine

Matriculation, Science; Art

Medical Pharmacology